THU0472 Amino Acid Position 10 in the HLA-DRB1 Protein Associates with Radiological Erosions in Early Active RA

Background Advances in imputation methods have enabled association studies of HLA protein amino acid polymorphisms and rheumatoid arthritis (RA) susceptibility. A recent meta-analysis of this region has attributed most of its association with seropositive RA to 5 amino acid positions [1]. Radiologic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of the rheumatic diseases 2014-06, Vol.73 (Suppl 2), p.346-347
Hauptverfasser: Scott, I.C., Quist, J., Spain, S.L., Tan, R., Steer, S., Cope, A.P., Lewis, C.M.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 347
container_issue Suppl 2
container_start_page 346
container_title Annals of the rheumatic diseases
container_volume 73
creator Scott, I.C.
Quist, J.
Spain, S.L.
Tan, R.
Steer, S.
Cope, A.P.
Lewis, C.M.
description Background Advances in imputation methods have enabled association studies of HLA protein amino acid polymorphisms and rheumatoid arthritis (RA) susceptibility. A recent meta-analysis of this region has attributed most of its association with seropositive RA to 5 amino acid positions [1]. Radiological progression in RA has a significant genetic component. Previous studies have linked shared-epitope alleles to radiological damage in RA; the association between HLA amino acid polymorphisms and radiological progression is unexplored. Objectives To evaluate the relationship between HLA amino acid polymorphisms and radiological progression (defined as the development of new erosions over 2 years) in early, active RA patients enrolled to a clinical trial. Methods The Combination Anti-Rheumatic Drugs in Early RA (CARDERA) trial randomised 467 patients to receive methotrexate with or without ciclosporin, corticosteroids or both treatments in a factorial-design. We evaluated 421 European ancestry patients with archived DNA (passing QC procedures) and radiological data available. Radiographs were evaluated 6-monthly (for 2 years) for the development of new erosions. Genotyping was performed on the ImmunoChip; HLA alleles and amino acid polymorphisms were imputed using SNP2HLA [2]. We evaluated 237 amino acid positions in 3 MHC class I and 5 MHC class II proteins and 255 HLA alleles for their association with new erosions. Association testing was performed using UNPHASED version 3.0.7, which utilises a standard retrospective likelihood model for a binary trait and allows the use of polymorphic markers [3]. A P-value threshold of 0.0002 was applied based on permutation testing. Ethical approval was obtained; all patients provided consent. Results One amino acid position, which was position 10 in HLA-DRβ1 (P=0.0001) passed our pre-defined significance threshold for association with new erosions. Using glutamine as the reference amino acid, the OR for new erosions with tyrosine was 0.443 (95% CI 0.278-0.706). A similar trend was observed for HLA alleles; the strongest association was seen with HLA-DRB1*04 (P-value=0.0002), which encodes glutamine at position 10. The absence of *04 alleles provided an OR for new erosions of 0.513 (95% CI 0.360-0.730). Conclusions We demonstrate an association between amino acid polymorphisms at position 10 in the HLA-DRβ1 protein and the development of radiological erosions in early active RA. Unlike amino acid polymorphisms associating
doi_str_mv 10.1136/annrheumdis-2014-eular.4069
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1777977838</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4008683501</sourcerecordid><originalsourceid>FETCH-LOGICAL-b1278-5c90342aa9ca587681ac9cca279e101b525678fa8c07025b50fbc55a7091a4473</originalsourceid><addsrcrecordid>eNqVkM1OwzAQhC0EEqXwDpZ6Tlnnz444hVIoUiWqqj1bjutQV0nc2gmoNy68KE-CQzlw5bTa0czs6kNoRGBMSJTeiqaxW9XVG-2CEEgcqK4SdhxDmp2hAYlT5uUUztEAAKIgzlJ6ia6c2_kVGGEDdFjN1hDT8OvjM691Y3Au9QYvjNOtNg0mgHWD263Cs3kePCzvCV5Y0yov5s4ZqUWrHH7X7RYvxUabyrxqKSo8tb7BNK5PT4Wtjr631W8KL_NrdFGKyqmb3zlE68fpajIL5i9Pz5N8HhQkpCxIZAZRHAqRSZEwmjIiZCalCGmmCJAiCZOUslIwCRTCpEigLGSSCAoZEXFMoyEanXr31hw65Vq-M51t_ElOKKUZpSxi3nV3ckn_sbOq5Hura2GPnADvGfM_jHnPmP8w5j1jn05P6aLe_Sv4DX-Chkc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1777977838</pqid></control><display><type>article</type><title>THU0472 Amino Acid Position 10 in the HLA-DRB1 Protein Associates with Radiological Erosions in Early Active RA</title><source>BMJ Journals - NESLi2</source><creator>Scott, I.C. ; Quist, J. ; Spain, S.L. ; Tan, R. ; Steer, S. ; Cope, A.P. ; Lewis, C.M.</creator><creatorcontrib>Scott, I.C. ; Quist, J. ; Spain, S.L. ; Tan, R. ; Steer, S. ; Cope, A.P. ; Lewis, C.M.</creatorcontrib><description>Background Advances in imputation methods have enabled association studies of HLA protein amino acid polymorphisms and rheumatoid arthritis (RA) susceptibility. A recent meta-analysis of this region has attributed most of its association with seropositive RA to 5 amino acid positions [1]. Radiological progression in RA has a significant genetic component. Previous studies have linked shared-epitope alleles to radiological damage in RA; the association between HLA amino acid polymorphisms and radiological progression is unexplored. Objectives To evaluate the relationship between HLA amino acid polymorphisms and radiological progression (defined as the development of new erosions over 2 years) in early, active RA patients enrolled to a clinical trial. Methods The Combination Anti-Rheumatic Drugs in Early RA (CARDERA) trial randomised 467 patients to receive methotrexate with or without ciclosporin, corticosteroids or both treatments in a factorial-design. We evaluated 421 European ancestry patients with archived DNA (passing QC procedures) and radiological data available. Radiographs were evaluated 6-monthly (for 2 years) for the development of new erosions. Genotyping was performed on the ImmunoChip; HLA alleles and amino acid polymorphisms were imputed using SNP2HLA [2]. We evaluated 237 amino acid positions in 3 MHC class I and 5 MHC class II proteins and 255 HLA alleles for their association with new erosions. Association testing was performed using UNPHASED version 3.0.7, which utilises a standard retrospective likelihood model for a binary trait and allows the use of polymorphic markers [3]. A P-value threshold of 0.0002 was applied based on permutation testing. Ethical approval was obtained; all patients provided consent. Results One amino acid position, which was position 10 in HLA-DRβ1 (P=0.0001) passed our pre-defined significance threshold for association with new erosions. Using glutamine as the reference amino acid, the OR for new erosions with tyrosine was 0.443 (95% CI 0.278-0.706). A similar trend was observed for HLA alleles; the strongest association was seen with HLA-DRB1*04 (P-value=0.0002), which encodes glutamine at position 10. The absence of *04 alleles provided an OR for new erosions of 0.513 (95% CI 0.360-0.730). Conclusions We demonstrate an association between amino acid polymorphisms at position 10 in the HLA-DRβ1 protein and the development of radiological erosions in early active RA. Unlike amino acid polymorphisms associating with RA susceptibility (located in binding grooves) this polymorphism influences β- and α-chain binding; it could therefore influence radiological damage through attenuating antigen presentation within the joint. Replication of our finding in other cohorts is required to confirm its validity. References Raychaudhuri S et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet 2012 29; 44: 291-6. Jia X et al. Imputing amino acid polymorphisms in human leukocyte antigens. PLoS One 2013; 8: e64683. Dudbridge F. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 2008; 66: 87-98. Acknowledgements Arthritis Research UK (Grant Reference Number 19739 to ICS); National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. Disclosure of Interest : None declared DOI 10.1136/annrheumdis-2014-eular.4069</description><identifier>ISSN: 0003-4967</identifier><identifier>EISSN: 1468-2060</identifier><identifier>DOI: 10.1136/annrheumdis-2014-eular.4069</identifier><identifier>CODEN: ARDIAO</identifier><language>eng</language><publisher>Kidlington: Elsevier Limited</publisher><ispartof>Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.346-347</ispartof><rights>2014, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>Copyright: 2014 (c) 2014, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://ard.bmj.com/content/73/Suppl_2/346.2.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://ard.bmj.com/content/73/Suppl_2/346.2.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,780,784,3187,23562,27915,27916,77361,77392</link.rule.ids></links><search><creatorcontrib>Scott, I.C.</creatorcontrib><creatorcontrib>Quist, J.</creatorcontrib><creatorcontrib>Spain, S.L.</creatorcontrib><creatorcontrib>Tan, R.</creatorcontrib><creatorcontrib>Steer, S.</creatorcontrib><creatorcontrib>Cope, A.P.</creatorcontrib><creatorcontrib>Lewis, C.M.</creatorcontrib><title>THU0472 Amino Acid Position 10 in the HLA-DRB1 Protein Associates with Radiological Erosions in Early Active RA</title><title>Annals of the rheumatic diseases</title><description>Background Advances in imputation methods have enabled association studies of HLA protein amino acid polymorphisms and rheumatoid arthritis (RA) susceptibility. A recent meta-analysis of this region has attributed most of its association with seropositive RA to 5 amino acid positions [1]. Radiological progression in RA has a significant genetic component. Previous studies have linked shared-epitope alleles to radiological damage in RA; the association between HLA amino acid polymorphisms and radiological progression is unexplored. Objectives To evaluate the relationship between HLA amino acid polymorphisms and radiological progression (defined as the development of new erosions over 2 years) in early, active RA patients enrolled to a clinical trial. Methods The Combination Anti-Rheumatic Drugs in Early RA (CARDERA) trial randomised 467 patients to receive methotrexate with or without ciclosporin, corticosteroids or both treatments in a factorial-design. We evaluated 421 European ancestry patients with archived DNA (passing QC procedures) and radiological data available. Radiographs were evaluated 6-monthly (for 2 years) for the development of new erosions. Genotyping was performed on the ImmunoChip; HLA alleles and amino acid polymorphisms were imputed using SNP2HLA [2]. We evaluated 237 amino acid positions in 3 MHC class I and 5 MHC class II proteins and 255 HLA alleles for their association with new erosions. Association testing was performed using UNPHASED version 3.0.7, which utilises a standard retrospective likelihood model for a binary trait and allows the use of polymorphic markers [3]. A P-value threshold of 0.0002 was applied based on permutation testing. Ethical approval was obtained; all patients provided consent. Results One amino acid position, which was position 10 in HLA-DRβ1 (P=0.0001) passed our pre-defined significance threshold for association with new erosions. Using glutamine as the reference amino acid, the OR for new erosions with tyrosine was 0.443 (95% CI 0.278-0.706). A similar trend was observed for HLA alleles; the strongest association was seen with HLA-DRB1*04 (P-value=0.0002), which encodes glutamine at position 10. The absence of *04 alleles provided an OR for new erosions of 0.513 (95% CI 0.360-0.730). Conclusions We demonstrate an association between amino acid polymorphisms at position 10 in the HLA-DRβ1 protein and the development of radiological erosions in early active RA. Unlike amino acid polymorphisms associating with RA susceptibility (located in binding grooves) this polymorphism influences β- and α-chain binding; it could therefore influence radiological damage through attenuating antigen presentation within the joint. Replication of our finding in other cohorts is required to confirm its validity. References Raychaudhuri S et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet 2012 29; 44: 291-6. Jia X et al. Imputing amino acid polymorphisms in human leukocyte antigens. PLoS One 2013; 8: e64683. Dudbridge F. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 2008; 66: 87-98. Acknowledgements Arthritis Research UK (Grant Reference Number 19739 to ICS); National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. Disclosure of Interest : None declared DOI 10.1136/annrheumdis-2014-eular.4069</description><issn>0003-4967</issn><issn>1468-2060</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqVkM1OwzAQhC0EEqXwDpZ6Tlnnz444hVIoUiWqqj1bjutQV0nc2gmoNy68KE-CQzlw5bTa0czs6kNoRGBMSJTeiqaxW9XVG-2CEEgcqK4SdhxDmp2hAYlT5uUUztEAAKIgzlJ6ia6c2_kVGGEDdFjN1hDT8OvjM691Y3Au9QYvjNOtNg0mgHWD263Cs3kePCzvCV5Y0yov5s4ZqUWrHH7X7RYvxUabyrxqKSo8tb7BNK5PT4Wtjr631W8KL_NrdFGKyqmb3zlE68fpajIL5i9Pz5N8HhQkpCxIZAZRHAqRSZEwmjIiZCalCGmmCJAiCZOUslIwCRTCpEigLGSSCAoZEXFMoyEanXr31hw65Vq-M51t_ElOKKUZpSxi3nV3ckn_sbOq5Hura2GPnADvGfM_jHnPmP8w5j1jn05P6aLe_Sv4DX-Chkc</recordid><startdate>201406</startdate><enddate>201406</enddate><creator>Scott, I.C.</creator><creator>Quist, J.</creator><creator>Spain, S.L.</creator><creator>Tan, R.</creator><creator>Steer, S.</creator><creator>Cope, A.P.</creator><creator>Lewis, C.M.</creator><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>201406</creationdate><title>THU0472 Amino Acid Position 10 in the HLA-DRB1 Protein Associates with Radiological Erosions in Early Active RA</title><author>Scott, I.C. ; Quist, J. ; Spain, S.L. ; Tan, R. ; Steer, S. ; Cope, A.P. ; Lewis, C.M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b1278-5c90342aa9ca587681ac9cca279e101b525678fa8c07025b50fbc55a7091a4473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Scott, I.C.</creatorcontrib><creatorcontrib>Quist, J.</creatorcontrib><creatorcontrib>Spain, S.L.</creatorcontrib><creatorcontrib>Tan, R.</creatorcontrib><creatorcontrib>Steer, S.</creatorcontrib><creatorcontrib>Cope, A.P.</creatorcontrib><creatorcontrib>Lewis, C.M.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Annals of the rheumatic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Scott, I.C.</au><au>Quist, J.</au><au>Spain, S.L.</au><au>Tan, R.</au><au>Steer, S.</au><au>Cope, A.P.</au><au>Lewis, C.M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>THU0472 Amino Acid Position 10 in the HLA-DRB1 Protein Associates with Radiological Erosions in Early Active RA</atitle><jtitle>Annals of the rheumatic diseases</jtitle><date>2014-06</date><risdate>2014</risdate><volume>73</volume><issue>Suppl 2</issue><spage>346</spage><epage>347</epage><pages>346-347</pages><issn>0003-4967</issn><eissn>1468-2060</eissn><coden>ARDIAO</coden><abstract>Background Advances in imputation methods have enabled association studies of HLA protein amino acid polymorphisms and rheumatoid arthritis (RA) susceptibility. A recent meta-analysis of this region has attributed most of its association with seropositive RA to 5 amino acid positions [1]. Radiological progression in RA has a significant genetic component. Previous studies have linked shared-epitope alleles to radiological damage in RA; the association between HLA amino acid polymorphisms and radiological progression is unexplored. Objectives To evaluate the relationship between HLA amino acid polymorphisms and radiological progression (defined as the development of new erosions over 2 years) in early, active RA patients enrolled to a clinical trial. Methods The Combination Anti-Rheumatic Drugs in Early RA (CARDERA) trial randomised 467 patients to receive methotrexate with or without ciclosporin, corticosteroids or both treatments in a factorial-design. We evaluated 421 European ancestry patients with archived DNA (passing QC procedures) and radiological data available. Radiographs were evaluated 6-monthly (for 2 years) for the development of new erosions. Genotyping was performed on the ImmunoChip; HLA alleles and amino acid polymorphisms were imputed using SNP2HLA [2]. We evaluated 237 amino acid positions in 3 MHC class I and 5 MHC class II proteins and 255 HLA alleles for their association with new erosions. Association testing was performed using UNPHASED version 3.0.7, which utilises a standard retrospective likelihood model for a binary trait and allows the use of polymorphic markers [3]. A P-value threshold of 0.0002 was applied based on permutation testing. Ethical approval was obtained; all patients provided consent. Results One amino acid position, which was position 10 in HLA-DRβ1 (P=0.0001) passed our pre-defined significance threshold for association with new erosions. Using glutamine as the reference amino acid, the OR for new erosions with tyrosine was 0.443 (95% CI 0.278-0.706). A similar trend was observed for HLA alleles; the strongest association was seen with HLA-DRB1*04 (P-value=0.0002), which encodes glutamine at position 10. The absence of *04 alleles provided an OR for new erosions of 0.513 (95% CI 0.360-0.730). Conclusions We demonstrate an association between amino acid polymorphisms at position 10 in the HLA-DRβ1 protein and the development of radiological erosions in early active RA. Unlike amino acid polymorphisms associating with RA susceptibility (located in binding grooves) this polymorphism influences β- and α-chain binding; it could therefore influence radiological damage through attenuating antigen presentation within the joint. Replication of our finding in other cohorts is required to confirm its validity. References Raychaudhuri S et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet 2012 29; 44: 291-6. Jia X et al. Imputing amino acid polymorphisms in human leukocyte antigens. PLoS One 2013; 8: e64683. Dudbridge F. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 2008; 66: 87-98. Acknowledgements Arthritis Research UK (Grant Reference Number 19739 to ICS); National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. Disclosure of Interest : None declared DOI 10.1136/annrheumdis-2014-eular.4069</abstract><cop>Kidlington</cop><pub>Elsevier Limited</pub><doi>10.1136/annrheumdis-2014-eular.4069</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0003-4967
ispartof Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.346-347
issn 0003-4967
1468-2060
language eng
recordid cdi_proquest_journals_1777977838
source BMJ Journals - NESLi2
title THU0472 Amino Acid Position 10 in the HLA-DRB1 Protein Associates with Radiological Erosions in Early Active RA
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T03%3A56%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=THU0472%E2%80%85Amino%20Acid%20Position%2010%20in%20the%20HLA-DRB1%20Protein%20Associates%20with%20Radiological%20Erosions%20in%20Early%20Active%20RA&rft.jtitle=Annals%20of%20the%20rheumatic%20diseases&rft.au=Scott,%20I.C.&rft.date=2014-06&rft.volume=73&rft.issue=Suppl%202&rft.spage=346&rft.epage=347&rft.pages=346-347&rft.issn=0003-4967&rft.eissn=1468-2060&rft.coden=ARDIAO&rft_id=info:doi/10.1136/annrheumdis-2014-eular.4069&rft_dat=%3Cproquest_cross%3E4008683501%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1777977838&rft_id=info:pmid/&rfr_iscdi=true